A Multi-Center, Randomized, Open-Label, Positive-Controlled Phase II Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction and Maintenance of General Anesthesia in Elective Surgery Patients.
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Cipepofol (Primary) ; Propofol
- Indications Anaesthesia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sichuan Haisike Pharmaceutical
Most Recent Events
- 16 Dec 2020 Status changed from recruiting to completed.
- 07 Jan 2020 Planned End Date changed from 30 Nov 2019 to 30 Nov 2020.
- 07 Jan 2020 Planned primary completion date changed from 30 Oct 2019 to 30 Oct 2020.